Nokia’s troubled digital health business

By Sophie Chapman
The Finnish communications technology firm, Nokia, is to re-strategise its digital health business following disappointing results. The company acquire...

The Finnish communications technology firm, Nokia, is to re-strategise its digital health business following disappointing results.

The company acquired the French startup, Withings, two years ago for US$191mn.

Nokia bought Withings, the digital company specialising in activity trackers and digital thermometers, in a bid to enter the health industry.

However, the Finnish firm noted $175mn of goodwill recorded in the third quarter of last year.

SEE ALSO:

Due to the business not being as successful as it had hoped for, Nokia has announced plans to evaluate plans with its health branch.

“The strategic review of the Digital Health business may or may not result in any transaction or other changes,” the company stated.

According to Reuters, the review of the digital health arm could lead to 425 jobs being cut in Finland, where it employs 6,300 people.

The company’s aim to reduce employees follows the announcement of $1.5bn savings plan revealed after the acquisition of Alcatel-Lucent in 2016.

Share

Featured Articles

PA Consulting: People Want 'Stackable' Healthcare Products

PA Consulting report shows people want ‘stackable’ personalised healthcare products and services that leverage personal data

HIV Testing Landmark Highlights Ongoing AIDS Problems

As US healthcare solutions specialist RMI passes the 350-million HIV testing kit mark, we look at the current HIV/AIDS situation globally

Schneider's Blum on Electricity 4.0 and Healthcare

Olivier Blum, EVP of Schneider Electric’s Energy Management business tells Healthcare Digital how Electricity 4.0 can improve people's wellbeing

Research Breakthrough Promises New Lupus Treatments

Medical Devices & Pharma

Healthcare Systems Worldwide Hit by Global IT Outage

Technology & AI

Abbott Labs' profits soar; Nipro opens First US Facility

Medical Devices & Pharma